Selected research
Market Structure
Global Soluble Guanylate Cyclase (sGC) Stimulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Soluble Guanylate Cyclase (sGC) Stimulators market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Soluble Guanylate Cyclase (sGC) Stimulators include Cipla, Dr Reddy's Laboratories, MSN, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Soluble Guanylate Cyclase (sGC) Stimulators market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Soluble Guanylate Cyclase (sGC) Stimulators and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Soluble Guanylate Cyclase (sGC) Stimulators sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Soluble Guanylate Cyclase (sGC) Stimulators market size, projected growth trends, production technologies, key applications, and end-use industries.
Soluble Guanylate Cyclase (sGC) Stimulators Segment by Company
Cipla
Dr Reddy's Laboratories
MSN
Bayer
Merck
Soluble Guanylate Cyclase (sGC) Stimulators Segment by Type
Vericiguat
Riociguat
Soluble Guanylate Cyclase (sGC) Stimulators Segment by Application
Chronic Thromboembolic Pulmonary Hypertension
Chronic Heart Failure
Pulmonary Hypertension
Other
Soluble Guanylate Cyclase (sGC) Stimulators Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soluble Guanylate Cyclase (sGC) Stimulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Soluble Guanylate Cyclase (sGC) Stimulators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soluble Guanylate Cyclase (sGC) Stimulators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Soluble Guanylate Cyclase (sGC) Stimulators market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soluble Guanylate Cyclase (sGC) Stimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Soluble Guanylate Cyclase (sGC) Stimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Soluble Guanylate Cyclase (sGC) Stimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Vericiguat
- Riociguat
Applications
- Chronic Thromboembolic Pulmonary Hypertension
- Chronic Heart Failure
- Pulmonary Hypertension
- Other
Companies covered
- Cipla
- Dr Reddy's Laboratories
- MSN
- Bayer
- Merck
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Soluble Guanylate Cyclase (sGC) Stimulators Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Soluble Guanylate Cyclase (sGC) Stimulators Market Dynamics
- 2.1 Soluble Guanylate Cyclase (sGC) Stimulators Industry Trends
- 2.2 Soluble Guanylate Cyclase (sGC) Stimulators Industry Drivers
- 2.3 Soluble Guanylate Cyclase (sGC) Stimulators Industry Opportunities and Challenges
- 2.4 Soluble Guanylate Cyclase (sGC) Stimulators Industry Restraints
3 Soluble Guanylate Cyclase (sGC) Stimulators Market by Manufacturers
- 3.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Manufacturers (2021-2026)
- 3.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Manufacturers (2021-2026)
- 3.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Soluble Guanylate Cyclase (sGC) Stimulators Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Soluble Guanylate Cyclase (sGC) Stimulators Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Soluble Guanylate Cyclase (sGC) Stimulators Manufacturers, Product Type & Application
- 3.7 Global Soluble Guanylate Cyclase (sGC) Stimulators Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Soluble Guanylate Cyclase (sGC) Stimulators Players Market Share by Revenue in 2025
- 3.8.3 2025 Soluble Guanylate Cyclase (sGC) Stimulators Tier 1, Tier 2, and Tier 3
4 Soluble Guanylate Cyclase (sGC) Stimulators Market by Type
- 4.1 Soluble Guanylate Cyclase (sGC) Stimulators Type Introduction
- 4.1.1 Vericiguat
- 4.1.2 Riociguat
- 4.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Type
- 4.2.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Type (2021-2032)
- 4.2.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Type (2021-2032)
- 4.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Type
- 4.3.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Type (2021-2032)
- 4.3.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Type (2021-2032)
5 Soluble Guanylate Cyclase (sGC) Stimulators Market by Application
- 5.1 Soluble Guanylate Cyclase (sGC) Stimulators Application Introduction
- 5.1.1 Chronic Thromboembolic Pulmonary Hypertension
- 5.1.2 Chronic Heart Failure
- 5.1.3 Pulmonary Hypertension
- 5.1.4 Other
- 5.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Application
- 5.2.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Application (2021-2032)
- 5.2.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Application (2021-2032)
- 5.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Application
- 5.3.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Application (2021-2032)
- 5.3.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Application (2021-2032)
6 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region
- 6.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region (2021-2032)
- 6.2.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region (2021-2026)
- 6.2.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region
- 7.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region
- 7.1.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region (2021-2026)
- 7.1.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region (2027-2032)
- 7.1.4 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032)
- 7.2.2 North America Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032)
- 7.3.2 Europe Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032)
- 7.4.2 Asia-Pacific Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Cipla
- 8.1.1 Cipla Company Information
- 8.1.2 Cipla Business Overview
- 8.1.3 Cipla Soluble Guanylate Cyclase (sGC) Stimulators Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Cipla Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
- 8.1.5 Cipla Recent Developments
- 8.2 Dr Reddy's Laboratories
- 8.2.1 Dr Reddy's Laboratories Company Information
- 8.2.2 Dr Reddy's Laboratories Business Overview
- 8.2.3 Dr Reddy's Laboratories Soluble Guanylate Cyclase (sGC) Stimulators Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Dr Reddy's Laboratories Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
- 8.2.5 Dr Reddy's Laboratories Recent Developments
- 8.3 MSN
- 8.3.1 MSN Company Information
- 8.3.2 MSN Business Overview
- 8.3.3 MSN Soluble Guanylate Cyclase (sGC) Stimulators Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 MSN Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
- 8.3.5 MSN Recent Developments
- 8.4 Bayer
- 8.4.1 Bayer Company Information
- 8.4.2 Bayer Business Overview
- 8.4.3 Bayer Soluble Guanylate Cyclase (sGC) Stimulators Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bayer Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
- 8.4.5 Bayer Recent Developments
- 8.5 Merck
- 8.5.1 Merck Company Information
- 8.5.2 Merck Business Overview
- 8.5.3 Merck Soluble Guanylate Cyclase (sGC) Stimulators Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Merck Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
- 8.5.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Soluble Guanylate Cyclase (sGC) Stimulators Value Chain Analysis
- 9.1.1 Soluble Guanylate Cyclase (sGC) Stimulators Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Soluble Guanylate Cyclase (sGC) Stimulators Production Mode & Process
- 9.2 Soluble Guanylate Cyclase (sGC) Stimulators Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Soluble Guanylate Cyclase (sGC) Stimulators Distributors
- 9.2.3 Soluble Guanylate Cyclase (sGC) Stimulators Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst